ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 169 filers reported holding ZAI LAB LTD in Q3 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $104,760 | -31.4% | 6,045 | -36.6% | 0.02% | -21.1% |
| Q1 2024 | $152,671 | -3.7% | 9,530 | +64.3% | 0.02% | -38.7% |
| Q4 2023 | $158,569 | +375.8% | 5,802 | +323.2% | 0.03% | +210.0% |
| Q3 2023 | $33,329 | +47.7% | 1,371 | +68.4% | 0.01% | +42.9% |
| Q2 2023 | $22,572 | -28.2% | 814 | -13.9% | 0.01% | -36.4% |
| Q1 2023 | $31,431 | +46.0% | 945 | +34.8% | 0.01% | +22.2% |
| Q4 2022 | $21,521 | -2.2% | 701 | +7.8% | 0.01% | 0.0% |
| Q3 2022 | $22,000 | – | 650 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 106,171 | $2,938 | 14.16% |
| Genesis Investment Management, LLP | 1,352,222 | $37,420,559 | 4.06% |
| Segantii Capital Management Ltd | 1,795,479 | $49,788,633 | 2.59% |
| HSG Holding Ltd | 694,634 | $19,262,201 | 2.20% |
| Paradigm Biocapital Advisors LP | 865,297 | $23,994,686 | 1.85% |
| INDUS CAPITAL PARTNERS, LLC | 25,256 | $700,349 | 1.41% |
| Privium Fund Management B.V. | 240,683 | $6,366,065 | 1.34% |
| Vivo Capital, LLC | 445,505 | $12,353,854 | 0.85% |
| Rock Springs Capital Management LP | 1,222,423 | $33,897,790 | 0.81% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 78,958 | $2,189,505 | 0.67% |